Picture a medical representative walking into a pharmacy, handing over a strip of Pantoprazole samples and a box of a newer molecule, signing a register, and leaving in four minutes. The pharmacist sets the samples on the shelf next to the purchased stock and moves on. Three weeks later, the system says there are 14 units of Pantoprazole. A physical count finds 19. Nobody stole anything. Nobody made an entry error. The five extra units arrived for free and were never logged. That five-unit gap is not a rounding problem — it is the beginning of a compliance risk, a GST mismatch, and a slow drain on the accuracy of every reorder decision you make this month.
If this happens twice a week across four or five visiting MRs, your inventory count is wrong by design. That wrongness has a cost attached to it, and we will show you where it comes from before the end of this post.
The Invisible Stock That Quietly Inflates Your Physical Count
A standard MR visit to a retail pharmacy produces two or three free sample packs — sometimes more during a product launch. These packs carry a printed MRP but were received at zero cost. Many billing setups have no dedicated workflow for logging zero-cost inward stock. The pharmacist either ignores the entry entirely or manually adjusts a purchase order, which creates a phantom purchase the accountant has to unwind later.
The result: physical stock is higher than system stock. When the next purchase order fires — either manually or via an automated reorder trigger — the system underestimates what is already on the shelf and may order more than needed. Every unit over-ordered this way sits in slow-moving stock, and some of it expires without ever being sold — quietly, from one source of slippage alone.
Your Schedule H/H1 Register Has a Gap You May Not Have Noticed
Rule 65 of the Drugs and Cosmetics Rules requires a pharmacy to keep records of the drugs it receives and supplies, and every Schedule H1 supply must be entered in a separate register — the prescriber's name and address, the patient's name, the drug and its quantity — kept for three years (Rule 65(3)(h)). Selling a Schedule H1 drug without a prescription is punishable under Section 27(d) of the Drugs and Cosmetics Act, 1940: imprisonment of one to two years and a fine of not less than ₹20,000.
Free samples of Schedule H and H1 molecules need to be accounted for like any other stock, even at zero purchase value. That entry is easy to skip when a medical representative hands them over at the counter. The packs go to the dispensing shelf or, worse, into a separate drawer labeled "samples," and they are dispensed without any register record.
- The drug inspector does not distinguish between "purchased stock" and "sample stock" during an inspection. Both are on your premises. Both must be accounted for.
- A missing register entry for a Schedule H1 molecule is a direct compliance violation, regardless of how the stock arrived.
- Three years of unrecorded MR visit stock, at even two visits per week, is a meaningful audit exposure.
Picture a pharmacist running a self-audit and finding a couple of dozen unlogged sample packs of a Schedule H1 molecule, left across several MR visits over a few months. Every one of them is stock nobody can account for, and every one dispensed without an entry is a missing register line.
GST 5% and Free Samples — Keep Them Out of Your Sales Figures
After the 56th GST Council meeting (September 2025), the 12% slab was withdrawn and, from 22 September 2025, most finished pharmaceutical formulations under HSN 3004 carry 5% GST. Free samples still have to be handled cleanly on your side of the books.
The practical implication: if a pharmacist dispenses a free sample and records it as a sale (to avoid a stock discrepancy), the output GST figure becomes wrong. If the sample is dispensed and not recorded at all, the physical-versus-system gap widens. Neither path is clean. The only clean path is a proper inward entry at zero cost, a correct dispensing record, and no GST output generated on a zero-revenue transaction — but that requires a billing system that can handle zero-cost inward stock without breaking its own ledger logic.
Many older setups cannot. The workaround is a manual journal entry, which usually gets skipped when the pharmacist is handling a busy afternoon.
What the Same Workflow Looks Like When Free Sample Stock Is Handled Correctly
A pharmacy that has a clean process for MR visit inventory typically runs like this:
| Step | Without a proper process | With a proper process |
|---|
| MR hands over samples | Placed on shelf, no entry | Logged as zero-cost inward stock immediately |
| Schedule H/H1 sample arrives | No record at all | Recorded as inward stock with its batch and expiry |
| Sample is dispensed | Either unrecorded or logged as a sale | Kept out of sales figures, with the stock count corrected |
| Month-end count | Physical and system disagree | Physical and system match |
| Reorder trigger fires | Based on inaccurate stock level | Based on accurate stock level |
The reorder accuracy alone is worth tracking: once samples are counted, you stop reordering stock you already have.
The compliance exposure shrinks as well. When every MR visit produces an inward entry, your stock records account for everything on the shelf, and there is no unexplained stock sitting there during an inspection.
How Nesayo Handles MR Visit Stock
Every MR visit is a small administrative event that nobody has time to process properly — so the entry has to be quick. In Nesayo, a sample pack is added to stock the same way as a purchased item: the catalogue of more than 2.5 lakh medicines already carries its HSN code and an H/H1 flag, and you enter the batch, expiry and quantity. Once it is on the shelf in Nesayo, it is counted. If a Schedule H1 medicine is later sold on a bill, the sale is logged at billing like any other H1 sale — patient, prescriber, medicine, batch, quantity — and the pharmacist adds the prescriber's address.
When a sample pack nears its expiry, Nesayo's Expiry Guard agent (on the Full plan) flags it before it becomes dead stock. The pharmacist does not have to remember to check; the alert arrives in the morning briefing. Stock Sense works from what is actually on the shelf, so its reorder suggestions account for what the MR left behind.
Billing on Nesayo is free forever (see current plan details at nesayo.com/pricing). As of October 2026, the Essential plan is ₹249 per month (voice billing, prescription scanning and Refill Radar) and the Full plan is ₹549 per month for all five agents — Morning Briefing, Expiry Guard, Refill Radar, Stock Sense and Payment Advisor. For pharmacies running on offline connections, the PWA offline billing mode keeps the dispensing counter running even when the internet drops; entries sync when the connection returns.
The Choice Is Simpler Than It Looks
Every MR visit that produces an unlogged sample pack is a small event with a compounding consequence: one more unit of inaccurate stock, one more missing register entry, one more number that the reorder system cannot trust. Over a year of twice-weekly MR visits, that compounds into a meaningful compliance exposure and a purchase order history that does not reflect reality. The pharmacies that fix this early spend an afternoon on setup. The ones that wait fix it during an inspection, under pressure, with months of missing entries to reconstruct.
Spend 2 minutes at nesayo.com/demo — a sample pharmacy is pre-loaded, no signup required. Look at how stock is added with its batch and expiry, and how a Schedule H1 medicine is flagged at billing — logged at the point it happens, not reconstructed at month-end.
FAQ
Will migrating to Nesayo mean I lose my existing purchase history and inventory data?
No. Nesayo supports CSV and Excel import for existing stock, the setup flow walks through it step by step, and our team will move your data across for you, free (file and photo imports run during your free first month of Full, or on a paid plan). Your existing records stay with you; Nesayo adds structure on top of them.
What if my staff is not comfortable with new software, or the internet goes down during billing?
Nesayo runs as a Progressive Web App, which means it works on any browser — phone, tablet, or desktop — without installation. The offline billing mode keeps the counter running during outages, and on the paid plans voice billing (beta) works in Hindi and English, so staff who find typing slow can speak the medicine name instead.
What is the catch with free billing — and can I really trust an AI system to handle Schedule H1 compliance?
There is no catch on billing. Nesayo's billing is free with no SKU cap or transaction limit, as of October 2026 (see nesayo.com/pricing for current terms). Schedule H1 sales are logged at billing (patient, prescriber, medicine, batch, quantity), and the pharmacist adds the prescriber's address. Whether a line counts as H1 is decided by rules — the medicine's schedule and a list of H1 salts — not by an AI judgment call. The catalogue of more than 2.5 lakh medicines is a reference, not an official list, so the pharmacist stays the final check. The AI agents handle alerts and recommendations.